Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Integrated DNA Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2789
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services such as analytics, custom label, OEM, and packaging and formulation. IDT offers diagnostic tests for genetic and infectious diseases, research to discover new drugs and treatments, and producing agricultural products. The company offers solutions in areas of academic research, biotechnology, and pharmaceutical development. It has operations in Germany, Belgium, Singapore, the UK and the US. IDT is headquartered in Skokie, Illinois, the US.

Integrated DNA Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10
Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11
Private Equity 12
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12
Partnerships 13
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15
Licensing Agreements 16
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16
Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17
Asset Transactions 18
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18
Acquisition 19
Danaher to Acquire Integrated DNA Technologies 19
Integrated DNA Technologies Acquires ValueGene 20
Integrated DNA Technologies Inc – Key Competitors 21
Integrated DNA Technologies Inc – Key Employees 22
Integrated DNA Technologies Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Product News 25
Jun 15, 2017: IDT raises the bar for PCR-based genotyping with novel rhAmp SNP solution 25
Feb 01, 2017: IDT first to market with complete Cpf1-based CRISPR genome editing system 26
Other Significant Developments 27
Mar 13, 2018: IDT supports genomics research with enhanced website 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 10
Integrated DNA to Acquire Oligonucleotide Business from AITbiotech 11
Summit Partners Acquires Minority Stake In Integrated DNA Technologies 12
Integrated DNA Enters into Co-Development Agreement with Ubiquitome 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 15
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 16
Caribou Biosciences Enters into Licensing Agreement with Integrated DNA Technologies for CRISPR-Cas9 Reagents 17
Integrated DNA Technologies Acquires Oligo Manufacturing Business from GeneWorks 18
Danaher to Acquire Integrated DNA Technologies 19
Integrated DNA Technologies Acquires ValueGene 20
Integrated DNA Technologies Inc, Key Competitors 21
Integrated DNA Technologies Inc, Key Employees 22
Integrated DNA Technologies Inc, Other Locations 23
Integrated DNA Technologies Inc, Subsidiaries 23

List of Figures
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Integrated DNA Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Integrated DNA Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gerdau S.A.:企業の戦略・SWOT・財務情報
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • Sancilio & Company Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sancilio & Company Inc (SCI), a subsidiary of Sancilio Pharmaceuticals Company Inc is a drug development company that develops, manufactures and markets over the counter and generic prescription products. The company provides products such as omega-3, ludent sodium fluoride chewable tablets …
  • Red Lion Hotels Corporation:企業の戦略・SWOT・財務情報
    Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bonterra Energy Corp (BNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonterra Energy Corp (Bonterra) is an oil and gas company. It acquires and develops producing or undeveloped oil and gas properties. It produces crude oil, natural gas and natural gas liquids. The company principally operates in the provinces of Alberta, British Columbia and Saskatchewan in …
  • Digimarc Corp (DMRC):企業の財務・戦略的SWOT分析
    Summary Digimarc Corp (Digimarc) is a technology company that offers develops solutions, license intellectual property and provides development services to businesses and government. The company offers products such as digimarc discover, online image safeguards and digimarc guardian. Digimarc’s Disc …
  • GE Healthcare LLC:医療機器:M&Aディール及び事業提携情報
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • CESC Ltd (CESC):企業の財務・戦略的SWOT分析
    CESC Ltd (CESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Altimmune UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs and develops immunotherapeutic products tailored to address a wide ra …
  • United Utilities Group PLC:企業の戦略・SWOT・財務分析
    United Utilities Group PLC - Strategy, SWOT and Corporate Finance Report Summary United Utilities Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nayara Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Nayara Energy Ltd (Nayara), formerly Essar Oil Ltd, a joint venture between Rosneft Oil Co, Trafigura Pte Ltd and UCP PE Investments Ltd, is a downstream company. It has presence in refining and marketing of oil refined products. The company operates a refinery at Vadinar in Gujarat, which i …
  • Mosenergo (MSNG):電力:M&Aディール及び事業提携情報
    Summary Mosenergo, a subsidiary of Gazprom Energoholding LLC, is a power utility. It generates electricity and thermal energy using natural gas, coal, fuel oil, and diesel sources. The company owns and operates power plants: TPP-20, SDPP-3, TPP-9, SPP-1, TPP-21, TPP-8, TPP-11, TPP-16, TPP-12, TPP-17 …
  • Tsakos Energy Navigation Ltd (TNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tsakos Energy Navigation Ltd (TEN), a subsidiary of Tsakos Group, is a marine transportation company that provides transportation services of crude oil, petroleum products and liquefied natural gas (LNG) to national and international oil companies and refineries. It charges customer on time …
  • FitLife Brands, Inc.:戦略・SWOT・企業財務分析
    FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Newfield Exploration Company:企業のM&A・事業提携・投資動向
    Newfield Exploration Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Newfield Exploration Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆